1. Limb vascular beds exhibit a graded dilatation in response to hypoxia de
spite increased sympathetic vasoconstrictor nerve activity. We investigated
the extent to which sympathetic vasoconstriction can mask hypoxic vasodila
tation and assessed the relative contributions of beta -adrenergic and nitr
ic oxide (NO) pathways to hypoxic vasodilatation.
2. We measured forearm blood flow responses (plethysmography) to isocapnic
hypoxia (arterial saturation similar to 85%) in eight healthy men and women
(18-26 years) after selective alpha -adrenergic blockade (phentolamine) of
one forearm. Subsequently, we measured hypoxic responses after combined al
pha- and beta -adrenergic blockade (phentolamine and propranolol) and after
combined alpha- and beta -adrenergic blockade coupled with NO synthase inh
ibition (N-G-monomethyl-L-arginine, L-NMMA).
3. Hypoxia increased forearm vascular conductance by 49.0 +/- 13.5% after p
hentolamine (compared to +16.8 +/- 7.0% in the control arm without phentola
mine, P < 0.05). After addition of propranolol, the forearm vascular conduc
tance response to hypoxia was reduced by -50%, but dilatation was still pre
sent (+24.7 +/- 7.0 %, P < 0.05 vs. normoxia). NT hen L-NMMA was added, the
re was no further reduction in the forearm vascular conductance response to
hypoxia (+28.2 +/- 4.0 %, P < 0.05 vs. normoxia).
4. Thus, selective regional <alpha>-adrenergic blockade unmasked a greater
hypoxic vasodilatation than occurs in the presence of functional Sympatheti
c nervous system responses to hypoxia. Furthermore, approximately half of t
he hypoxic vasodilatation in the forearm appears to be mediated by beta -ad
renergic receptor-mediated pathways. Finally, since considerable dilatation
persists in the presence of both beta -adrenergic blockade and NO synthase
inhibition, it is likely that an additional vasodilator mechanism is activ
ated by hypoxia in humans.